A combination phase I study of topotecan with cisplatin for elderly small cell lung cancer

Phase 1

• Conditions: small cell lung cancer

• Registration Number: JPRN-C000000143
• Lead Sponsor: Department of Medical Oncology, Kinki University School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-08
• Study Completion: 2007-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Not provided

Exclusion Criteria

1)Severe infection and complication (hemorrhage and heart disease etc.) 2)Intestinal pneumonia or lung fibrosis 3)Symptomatic brain metastasis 4)History of active other malignancy 5)History of severe drug allergic reaction 6)Pregnant women or women willing child-bearing 7)Men willing to have children 8)Uncontrolled diabetes 9)Uncontrolled pleural, cardiac, or abdominal effusion 10)Inadequate condition diagnosed by primary physician

Study & Design

• Study Type: Interventional
• Study Design: Not specified